WILHELMUS WENCESLAUS MATTHIAS PIJNAPPEL
Inventor
Stats
- 0 US patents issued
- 12 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 12 US Applications Filed
- 10 Total Citation Count
- Jun 6, 2022 Most Recent Filing
- Jun 10, 2015 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM | 2
| 2015
|
Inventor Addresses
Address | Duration |
---|---|
Rotterdam, NL | Aug 31, 17 - Jan 02, 24 |
Vleuten, NL | May 30, 19 - Jun 29, 23 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 5 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11859186 | 2024 | Antisense oligonucleotides useful in treatment of Pompe disease | 0 |
2023/0203,448 | 2023 | METHOD OF MANUFACTURING MICRODEVICES FOR LAB-ON-CHIP APPLICATIONS | 1 |
2022/0380,730 | 2022 | METHOD FOR CULTURING MYOGENIC CELLS, CULTURES OBTAINED THEREFROM, SCREENING METHODS, AND CELL CULTURE MEDIUM | 0 |
11352605 | 2022 | Method for culturing myogenic cells, cultures obtained therefrom, screening methods, and cell culture medium | 0 |
11286483 | 2022 | Enzymatic replacement therapy and antisense therapy for Pompe disease | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.